Scholars Central

Research articlePublished 3 May 2019

A validated RP-HPLC method for estimation of Rivastigmine in pharmaceutical formulations

Authors: S. Alexandar, Rohini Diwedi, T. Ashok, M. J. N. Chandrasekhar

Der Pharmacia Lettre

Volume 3 · Issue 3 · Pages 421–426

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

An isocratic RP-HPLC Method for analysis of Rivastigmine in pharmaceutical dosage forms has been developed and validated. Best separation was achieved on a Thermo Hypersil C4 column (25 cm X 4.6 mm, 5 μm) using a mobile phase of 0.01 M ammonium acetate buffer adjusted to pH 4.0 with orthophosphoric acid and Acetonitrile (60:40, v/v) at a flow rate of 1.0 mL min-1. UV detection was performed at 220 nm. Atrovastatin was used as an internal standard. The retention time of Rivastigmine and Atrovastatin was 4.75 and 8.83 min, respectively. The method was validated for specificity, linearity, precision, accuracy, and limit of quantification, limit of detection, robustness, and solution stability. The proposed method was applied for the quantitative determination of Rivastigmine in commercial formulations.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharmacia Lettre.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharmacia Lettre
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “S. Alexandar”
  • BylineArticles whose byline prints “Rohini Diwedi”
  • BylineArticles whose byline prints “T. Ashok”
  • BylineArticles whose byline prints “M. J. N. Chandrasekhar”